NFKB1 and melanoma: Considering our previous experience on the ability of esomeprazole, a proton pump inhibitor that requires acidosis for its activation, to prevent NF-κB activation [17, 28], we rocked for 48 hours acidic and nonacidic melanoma cells in the presence of esomeprazole.